On Tuesday, the CDC and FDA recommended that administration of Johnson & Johnson’s COVID-19 vaccine be paused while a possible connection to rare blood clots is investigated. 

The U.S. has continued a downward trend, with a 30% decrease in the number of daily COVID-19 tests.

The United States has suffered nearly one-fifth of the world’s COVID-19 deaths, even as it accounts for just over 4 percent of the world’s population.

Campaigns aimed at Black communities across the U.S. are making headway in the effort to persuade people that the COVID-19 vaccines are safe and effective. 

Last week, the Centers for Disease Control and Prevention announced that fully vaccinated people can now travel safely on mass transportation, including planes, in the United States.

Friday April 9, 2021 12:00-12:30 ET Join experts from the Johns Hopkins Coronavirus Resource Center (CRC) at 12pm ET on Fridays for timely, accessible updates on the state of the pandemic and the public health response.

Johns Hopkins Center for Health Security Senior Scholar Jennifer Nuzzo discusses COVID risks associated with crowd interactions and contact, concerns about the AstraZeneca Plc vaccine, and states removing mask mandates.

Chris Hayes is joined by Jennifer Nuzzo to discuss the distribution of vaccines around the world and spreading coronavirus variants.

In the past seven days, the U.S. reported slightly more than 65,000 new COVID-19 cases per day on average, a jump of 20% from two weeks earlier. 

Friday March 26, 2021 12:00-12:30 ET Join experts from the Johns Hopkins Coronavirus Resource Center (CRC) at 12pm ET on Fridays for timely, accessible updates on the state of the pandemic and the public health response.

Testing might be more important now than ever, and new testing technology and government funding and initiatives are making getting tested faster, easier, and cheaper than it’s ever been.

With case numbers still high, coronavirus testing remains essential, experts say, but the goals and approach will change as vaccines roll out.